Literature DB >> 21893980

Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients.

T Rizos1, A Wagner, E Jenetzky, P A Ringleb, R Becker, W Hacke, R Veltkamp.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a common cause of ischemic stroke and transient ischemic attack (TIA). More extensive diagnostic effort is required to detect paroxysmal AF (pxAF) than persistent AF (pAF); the prevalence of pxAF in stroke patients is unknown. We evaluated the prevalence of pAF and pxAF in ischemic stroke and TIA patients.
METHODS: Consecutive patients with acute ischemic stroke/TIA were enrolled prospectively. We aimed to detect patients with a history of AF, with AF newly diagnosed in the emergency room (ER), or with newly diagnosed AF during a 3-month period following the event. Differences in the frequency of AF diagnosis with respect to the disposition of patients after ER work-up were assessed.
RESULTS: A total of 692 patients were enrolled (male: 52.2%; ischemic stroke: 69.1%; TIA: 30.9%). A previously documented history of AF was present in 19.7% (pAF: 47.1%, pxAF: 52.9%). In 3.8% of patients, AF was newly diagnosed in the ER (pxAF: 61.5%) and in 5.2% during the 3-month follow-up period. The overall prevalence of AF was 28.6% (pxAF: 62.6%). Previously documented pxAF evaded diagnosis at ER presentation in 48.6%. The prevalence of AF increased with age (p < 0.001). Patients with pxAF were younger than those with pAF (p = 0.004) and more often female (p = 0.05). The presence of any AF was associated with higher initial NIHSS scores (p < 0.001) and higher modified Rankin scores after 3 months (p < 0.001).
CONCLUSION: pxAF occurs more often than pAF in stroke/TIA patients. As effective stroke prevention is available for AF, it is important to develop and evaluate sensitive methods for detecting pxAF.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21893980     DOI: 10.1159/000330348

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  13 in total

1.  Paroxysmal atrial fibrillation and the hazards of under-treatment.

Authors:  Konstantinos N Aronis; Jonathan L Thigpen; Yorghos Tripodis; Chrisly Dillon; Kristen Forster; Lori Henault; Emily Kate Quinn; Peter B Berger; Nita A Limdi; Elaine M Hylek
Journal:  Int J Cardiol       Date:  2015-09-11       Impact factor: 4.164

2.  Silent Atrial Fibrillation in Elderly Pacemaker Users: A Randomized Trial Using Home Monitoring.

Authors:  Ceb Lima; M Martinelli; G L Peixoto; S F Siqueira; Maurício Wajngarten; Rodrigo Tavares Silva; Roberto Costa; Roberto Filho; José Antônio Franchini Ramires
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-09-28       Impact factor: 1.468

3.  Occult paroxysmal atrial fibrillation in non-cryptogenic ischemic stroke.

Authors:  Jeffrey M Katz; Melissa S Eng; Claire Carrazco; Anand V Patel; Ram Jadonath; Michele Gribko; Rohan Arora; Richard B Libman
Journal:  J Neurol       Date:  2018-07-24       Impact factor: 4.849

4.  Intracerebral hemorrhage during anticoagulation with vitamin K antagonists: a consecutive observational study.

Authors:  S Horstmann; T Rizos; M Lauseker; M Möhlenbruch; E Jenetzky; W Hacke; Th Steiner; R Veltkamp
Journal:  J Neurol       Date:  2013-05-05       Impact factor: 4.849

5.  The value of STAF (Score for the Targeting of Atrial Fibrillation) in Patients with Cryptogenic Embolic Stroke.

Authors:  Eylem Özaydin Göksu; Burcu Yüksel; Murat Esin; Elif Küçükseymen; Ali Ünal; Ahmet Genç; Aylin Yaman
Journal:  Noro Psikiyatr Ars       Date:  2018-07-09       Impact factor: 1.339

6.  Detection of paroxysmal atrial fibrillation in stroke/tia patients.

Authors:  Muhib Khan; Daniel J Miller
Journal:  Stroke Res Treat       Date:  2013-03-26

7.  Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation.

Authors:  Johan Engdahl; Anders Holmén; Mårten Rosenqvist; Ulf Strömberg
Journal:  BMC Public Health       Date:  2013-08-03       Impact factor: 3.295

8.  Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial.

Authors:  Steven B Uittenbogaart; Nicole Verbiest-van Gurp; Petra M G Erkens; Wim A M Lucassen; J André Knottnerus; Bjorn Winkens; Henk C P M van Weert; Henri E J H Stoffers
Journal:  Trials       Date:  2015-10-23       Impact factor: 2.279

9.  Long-term Arrhythmia Monitoring in Cryptogenic Stroke: Who, How, and for How Long?

Authors:  Mayra Montalvo; Rushna Ali; Brian Silver; Muhib Khan
Journal:  Open Cardiovasc Med J       Date:  2016-05-27

Review 10.  Optimal Duration of Monitoring for Atrial Fibrillation in Cryptogenic Stroke: A Nonsystematic Review.

Authors:  Essa Hariri; Ahmad Hachem; Georges Sarkis; Samer Nasr
Journal:  Biomed Res Int       Date:  2016-05-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.